127 related articles for article (PubMed ID: 9057806)
1. Olsalazine-induced lupus syndrome.
Gunnarsson I; Pettersson E; Lindblad S; Ringertz B
Scand J Rheumatol; 1997; 26(1):65-6. PubMed ID: 9057806
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
Ewe K; Eckardt V; Kanzler G
Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
[TBL] [Abstract][Full Text] [Related]
3. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B
Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274
[TBL] [Abstract][Full Text] [Related]
4. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
Jewell DP; Ireland A
Scand J Gastroenterol Suppl; 1988; 148():45-7. PubMed ID: 2906477
[TBL] [Abstract][Full Text] [Related]
5. Olsalazine in the treatment of active ulcerative colitis: a placebo controlled clinical trial and assessment of drug disposition.
Hetzel DJ; Shearman DJ; Labrooy J; Bochner F; Imhoff DM; Gibson GE; Fitch RJ; Hecker R; Rowland R
Scand J Gastroenterol Suppl; 1988; 148():61-9. PubMed ID: 3067339
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
Rao SS; Cann PA; Holdsworth CD
Scand J Gastroenterol; 1987 Apr; 22(3):332-6. PubMed ID: 2884724
[TBL] [Abstract][Full Text] [Related]
7. The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine.
Støa-Birketvedt G; Florholmen J
Aliment Pharmacol Ther; 1999 Mar; 13(3):357-61. PubMed ID: 10102969
[TBL] [Abstract][Full Text] [Related]
8. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
Rao SS; Dundas SA; Holdsworth CD; Cann PA; Palmer KR; Corbett CL
Gut; 1989 May; 30(5):675-9. PubMed ID: 2567266
[TBL] [Abstract][Full Text] [Related]
9. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.
Kruis W; Judmaier G; Kayasseh L; Stolte M; Theuer D; Scheurlen C; Hentschel E; Kratochvil P
Eur J Gastroenterol Hepatol; 1995 May; 7(5):391-6. PubMed ID: 7614099
[TBL] [Abstract][Full Text] [Related]
10. Sulphasalazine-induced systemic lupus erythematosus in a child.
Vanheule BA; Carswell F
Eur J Pediatr; 1983 Mar; 140(1):66-8. PubMed ID: 6135611
[TBL] [Abstract][Full Text] [Related]
11. Olsalazine for ulcerative colitis.
Med Lett Drugs Ther; 1990 Nov; 32(831):105-6. PubMed ID: 2233512
[No Abstract] [Full Text] [Related]
12. Olsalazine in patients intolerant of sulphasalazine.
Ireland A; Jewell DP
Scand J Gastroenterol; 1987 Nov; 22(9):1038-40. PubMed ID: 2892247
[TBL] [Abstract][Full Text] [Related]
13. Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
Lauritsen K; Staerk Laursen L; Bukhave K; Rask-Madsen J
Gut; 1988 Jul; 29(7):974-82. PubMed ID: 2840367
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis.
Willoughby CP; Cowan RE; Gould SR; Machell RJ; Stewart JB
Scand J Gastroenterol Suppl; 1988; 148():40-4. PubMed ID: 2906476
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of olsalazine.
Campbell DE; Berglindh T
Scand J Gastroenterol Suppl; 1988; 148():7-12. PubMed ID: 3067340
[TBL] [Abstract][Full Text] [Related]
16. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
[TBL] [Abstract][Full Text] [Related]
17. Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.
Feurle GE; Theuer D; Velasco S; Barry BA; Wördehoff D; Sommer A; Jantschek G; Kruis W
Gut; 1989 Oct; 30(10):1354-61. PubMed ID: 2684804
[TBL] [Abstract][Full Text] [Related]
18. Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
Birketvedt GS; Berg KJ; Fausa O; Florholmen J
Inflamm Bowel Dis; 2000 Nov; 6(4):275-9. PubMed ID: 11149559
[TBL] [Abstract][Full Text] [Related]
19. Olsalazine in the treatment of mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind, clinical trial.
Feurle GE; Theuer D; Velasco S; Barry BA; Wördehoff D; Sommer A; Jantschegk Y; Kruis W
Scand J Gastroenterol Suppl; 1988; 148():38-9. PubMed ID: 3067338
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study.
Sandberg-Gertzén H; Järnerot G; Tysk C
Scand J Gastroenterol Suppl; 1988; 148():48-50. PubMed ID: 3227309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
